SAN DIEGO (November 13, 2019)—ResMed announced an upgraded AirView for Respiratory program that includes management by exception, providing HMEs and physicians with quicker access to essential respiratory patient data and allowing them to provide better quality care.
AirView
Cloud connectivity improves patient compliance
The new feature saves time and money for suppliers.
ATLANTA (September 12, 2017)—Managing compliance for sleep apnea patients and increasing resupply revenue just got easier for home medical equipment (HME) providers, as Brightree today announced automated resupply enrollment for patients managed by both Brightree and AirView by ResMed.
New integrations expands the company's ability to manage sleep therapy outcomes
ATLANTA (March 22, 2017)—Brightree a provider of cloud-based software for helping post-acute care companies improve business performance and patient outcomes, today announced that its home medical equipment (HME) billing and business management module has enhanced integration capabilities with AirView and myAir, ResMed’s cloud-based sleep and respiratory care patient management and patient engagement platforms.
The enhanced capabilities include:
SAN DIEGO (January 4, 2017)—ResMed today announced that it has achieved a new record in digital connected care: One billion nights of sleep data have been downloaded using ResMed's revolutionary remote patient monitoring platform, AirView.
ATLANTA (November 3, 2016)—ResMed announced two enhancements to AirView, a cloud-based remote patient monitoring platform that enables care teams to securely access therapy data from three million sleep apnea and respiratory care patients every day.
SAN FRANCISCO (May 16, 2016)—Patients using in-home life support and their clinicians are about to enjoy the latest in home health technology, remote patient monitoring, thanks to the world’s first cellular, cloud-connected in-home life support ventilators.
The Medicare Administrative Contractor for Jurisdiction B, National Government Services, will require suppliers to include a narrative explanation, effective Feb. 1, when submitting claims for test strips for a noninsulin treated diabetic beneficiary (KS modifier) in quantities of 10 or more units of service. The DME MAC reported that it is implementing the change because of a high volume of claims for diabetic test strips (A4253KS) with an incorrect number of services.